- Ovid Therapeutics Inc To Host Research & Development (R&D) Day TranscriptOct 02, 2023
- Ovid Therapeutics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Ovid Therapeutics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 14, 2022
- Ovid Therapeutics Inc at Ladenburg Thalmann Virtual Healthcare Conference TranscriptJul 14, 2021
- Ovid Therapeutics Inc Annual Shareholders Meeting TranscriptJun 10, 2021
- Ovid Therapeutics Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- Ovid Therapeutics Inc and Takeda Pharmaceutical Co Ltd to Discuss Strategic Transaction Call TranscriptMar 03, 2021
- Ovid Therapeutics Inc. - Special Call TranscriptOct 22, 2020
- Ovid Therapeutics Inc. - Special Call TranscriptAug 25, 2020
- Ovid Therapeutics Inc. - Special Call TranscriptJul 13, 2020
- Ovid Therapeutics Inc. - Special Call TranscriptJun 17, 2020
- Ovid Therapeutics Inc Annual Shareholders Meeting TranscriptJun 04, 2020
- Ovid Therapeutics to Discuss Positive Initial Data from Ongoing ENDYMION Trial Call TranscriptSep 23, 2019
- Ovid Therapeutics Inc. - Special Call TranscriptJun 27, 2019
Ovid Therapeutics Inc Annual Shareholders Meeting Transcript
You may now begin.
Thank you. Good morning, everybody. I'm Jeremy Levin, Chairman of the Board of Directors and Chief Executive Officer of Ovid Therapeutics, and it's my pleasure to welcome you to the company's 2020 Annual Meeting of Stockholders, which is being held virtually for the first time due to health and safety concerns caused by the COVID-19 pandemic.
It's now shortly after 11 a.m., and I'll call this meeting to order and proceed with introductions and formal business of the annual meeting. I'd like to start off by thanking everyone for joining us today.
Please let me introduce the members of our senior management team who are present today: Dr. Amit Rakhit, who is our President and Chief Medical Officer; Thomas Tom Perone, General Counsel and Corporate Secretary; Jason Tardio, our Chief Commercial Officer; and Mr. Jeff Rona, our Consulting Chief Financial Officer. We're also pleased to announce and to introduce the other members of our Board of Directors who will be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)